NDC 0832-0540 – Bumetanide
Bumetanide .5 mg/1 · Tablet · Oral
Product NDC0832-0540
Product details
- Brand name
- Bumetanide
- Generic name
- Bumetanide
- Labeler
- Upsher-Smith Laboratories, LLC
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA209916
- Marketed since
- January 30, 2018
- Marketing end
- September 30, 2026
- Pharmacologic class
- Loop Diuretic
Active ingredients
- Bumetanide .5 mg/1
Package NDC codes (0)
| Package NDC | Description | Since |
|---|
Recalls mentioning this NDC
- D-0280-2019 Oct 31, 2018 · Class II
Failed impurities/ degradation specifications: Product is Out of Specification for an unspecified degradation product. - D-0281-2019 Oct 31, 2018 · Class II
Failed impurities/ degradation specifications: Product is Out of Specification for an unspecified degradation product.
Other Bumetanide products
- 50090-6308 Bumetanide .5 mg/1 · Tablet · A-S Medication Solutions
- 50090-7736 Bumetanide .5 mg/1 · Tablet · A-S Medication Solutions
- 50090-7854 Bumetanide 2 mg/1 · Tablet · A-S Medication Solutions
- 50090-5666 Bumetanide 1 mg/1 · Tablet · A-S Medication Solutions
- 50090-6137 Bumetanide 2 mg/1 · Tablet · A-S Medication Solutions
- 50090-6138 Bumetanide 1 mg/1 · Tablet · A-S Medication Solutions
- 50090-6304 Bumetanide 2 mg/1 · Tablet · A-S Medication Solutions
- 50090-5664 Bumetanide .5 mg/1 · Tablet · A-S Medication Solutions
- 50090-5663 Bumetanide 2 mg/1 · Tablet · A-S Medication Solutions
- 50090-7350 Bumetanide 2 mg/1 · Tablet · A-S Medication Solutions
- 50090-7876 Bumetanide 2 mg/1 · Tablet · A-S Medication Solutions
- 50090-6345 Bumetanide 1 mg/1 · Tablet · A-S Medication Solutions